You are now leaving this website.
Are you sure?
NO
YES
  1. CORPORATE - 19-01-2016

    Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio

    Gains Commercial Rights in the U.S. to BIVIGAM®, a Recently Approved IGIV Brand

    read more 
  2. CORPORATE - 20-07-2015

    KEDPlasma welcomes donors to its new Augsburg collection center

    Plasma collected in Germany is essential to Kedrion Biopharma’s European plasma-derived therapies

    read more 
  3. EVENTS - 13-07-2015

    Tuscany Italy adopts revolutionary PID testing

    Kedrion S.p.A. at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies

    read more 
  4. CORPORATE - 29-06-2015

    Humanitarian programme augments access to clotting factors in developing countries

    Kedrion helps the WISH project come true: Italian CNS[NM1] and the World Federation of Hemophilia sign agreement in London

    read more 

Pages

For more information please contact: pressoffice@kedrion.com